中药复方逆转肝纤维化的作用机制OA
Mechanism of traditional Chinese medicine compound in reversing hepatic fibrosis
肝脏纤维化是多种慢性肝病(包括慢性病毒性肝炎、酒精性肝病、非酒精性脂肪性肝病、自身免疫性肝炎及胆汁淤积性肝病等)进展至肝硬化、肝细胞癌的核心病理阶段.其病程隐匿、进展缓慢,早期症状不典型,发展至中晚期会引发腹水、肝性脑病、消化道出血等严重并发症,对人类身心健康构成严重威胁,已成为全球重大公共卫生问题之一.与西医学中单一靶点的化学药物不同,中药复方基于中医整体观念与辨证论治核心原则,遵循多种中药的合理配伍,具有"多成分-多靶点-多途径"的本质特殊性,其成分复杂且协同作用,能够作用于肝纤维化发生、发展的多个病理环节,在抑制肝纤维化进展中展现出独到优势.近几年,随着医学技术与中医药理论的深度融合,中医药在抗肝纤维化临床研究领域取得了突破性进展,大量临床数据与实验研究证实了中药复方的确切疗效,同时也为深入解读中药复方抗肝纤维化的作用机制、明确其核心调控靶点与信号通路提供了稳固的理论支撑和实践依据.文章旨在立足于中医理论与现代药理研究成果,系统探讨中药复方抗肝纤维化的疗效机制研究方向和思路,梳理其多成分协同调控的核心逻辑,为中药复方在肝纤维化临床治疗中的精准应用、治疗方案优化及后续机制深入研究提供参考.
Hepatic fibrosis is a core pathological stage in the progression of various chronic liver diseases,including chronic viral hepatitis,alcoholic liver disease,non-alcoholic fatty liver disease,autoimmune hepatitis,and cholestatic liver disease,towards liver cirrhosis and hepatocellular carcinoma.It has an insidious onset and slow progression with atypical symptoms in the early stage.In the middle and advanced stages,it may lead to severe complications such as ascites,hepatic encephalopathy and gastrointestinal bleeding,which seriously endangers human physical and mental health and has become one of the major global public health problems.Different from single-target chemical drugs in Western medicine,traditional Chinese medicine(TCM)compound prescriptions are based on the core theories of holistic concept and syndrome differentiation and treatment of traditional Chinese medicine,and formulated via rational compatibility of multiple herbs.Characterized by the inherent property of multi-component,multi-target and multi-pathway,TCM compounds possess complicated components with synergistic effects.They can act on multiple pathological links during the occurrence and progression of hepatic fibrosis,and thus exert unique advantages in inhibiting the development of hepatic fibrosis.In recent years,with the in-depth integration of modern medical technology and traditional Chinese medicine theories,breakthrough progress has been made in clinical research on anti-hepatic fibrosis using TCM.A large number of clinical data and experimental studies have verified the definite curative effect of TCM compound prescriptions.Meanwhile,they provide solid theoretical support and practical evidence for further elucidating the mechanism of TCM compounds against hepatic fibrosis,as well as identifying their core regulatory targets and signaling pathways.This paper aims to systematically explore the research directions and ideas regarding the therapeutic mechanism of TCM compound prescriptions against hepatic fibrosis based on TCM theories and modern pharmacological research achievements.It sorts out the core logic of multi-component synergistic regulation,so as to provide scientific references for the precise clinical application,optimization of therapeutic regimens and in-depth follow-up mechanism research of TCM compounds in hepatic fibrosis.
周涵;王丰羽;殷太隆;王琳
山东中医药大学第一临床医学院,山东 济南,250014山东中医药大学第一临床医学院,山东 济南,250014山东中医药大学第一临床医学院,山东 济南,250014青岛市中医医院/青岛大学附属青岛市海慈医院,山东 青岛,266033
医药卫生
肝纤维化中药复方作用机制
Hepatic fibrosisTraditional Chinese medicine compoundMechanism of action
《中医临床研究》 2026 (18)
46-52,7
全国名老中医专家传承工作室建设项目(国中医药人教函[2022]75号)2023年度山东省中医药科技项目(青岛市卫生健康委员会):基于网络药理学和分子对接技术探讨谢旭善教授治疗乙肝肝硬化用药物配伍规律及作用机制的研究(M-2023243)青岛市2022年度医药卫生科研指导项目:基于网络药理学和分子对接技术探讨护肠清毒微丸治疗慢性肝衰竭大鼠肠源性内毒素血症机制的研究(2022-WJZD044).
评论